{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:20:56Z","timestamp":1767864056369,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":684,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000897","name":"Canadian Cystic Fibrosis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.07.009","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T19:31:45Z","timestamp":1311535905000},"page":"6540-6548","source":"Crossref","is-referenced-by-count":55,"title":["Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis"],"prefix":"10.1016","volume":"29","author":[{"given":"Srinivas","family":"Garlapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson F.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadele G.","family":"Kiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Kindrachuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K.","family":"Mutwiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorne A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2011.07.009_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.009_bib0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2011.07.009_bib0030","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/S0264-410X(02)00295-5","article-title":"Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines","volume":"20","author":"Joseph","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.009_bib0035","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"J Immunol"},{"issue":"29","key":"10.1016\/j.vaccine.2011.07.009_bib0040","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1016\/j.vaccine.2007.05.007","article-title":"Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen","volume":"25","author":"Mullen","year":"2007","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2011.07.009_bib0045","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.vaccine.2008.03.005","article-title":"Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders","volume":"26","author":"Qian","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.009_bib0050","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.49.5.1727-1732.2005","article-title":"Immunomodulatory activities of small host defense peptides","volume":"49","author":"Bowdish","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.vaccine.2011.07.009_bib0055","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.07.009_bib0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.intimp.2011.01.028","article-title":"CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo","volume":"11","author":"Cao","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"37","key":"10.1016\/j.vaccine.2011.07.009_bib0065","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/j.vaccine.2010.06.103","article-title":"Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets","volume":"28","author":"Cao","year":"2010","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.vaccine.2011.07.009_bib0070","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2009.05.094","article-title":"A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity","volume":"27","author":"Kindrachuk","year":"2009","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2011.07.009_bib0075","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1016\/j.vaccine.2010.09.080","article-title":"PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice","volume":"28","author":"Garlapati","year":"2010","journal-title":"Vaccine"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2011.07.009_bib0080","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1099\/vir.0.011684-0","article-title":"Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice","volume":"90","author":"Kovacs-Nolan","year":"2009","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.009_bib0090","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ije\/dym142","article-title":"Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines","volume":"36","author":"Chan","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.009_bib0095","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.009_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.009_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cellsig.2007.09.003","article-title":"Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling","volume":"20","author":"Lee","year":"2008","journal-title":"Cell Signal"},{"issue":"11","key":"10.1016\/j.vaccine.2011.07.009_bib0115","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells","volume":"177","author":"Higgins","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.009_bib0120","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2011.07.009_bib0125","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2011.07.009_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0142-9612(97)00227-5","article-title":"Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions","volume":"19","author":"Andrianov","year":"1998","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.vaccine.2011.07.009_bib0135","first-page":"767","article-title":"Polymeric drugs drug delivery systems","volume":"1","author":"Andrianov","year":"1998","journal-title":"IDrugs"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.009_bib0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.009_bib0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2011.07.009_bib0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.009_bib0155","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/IAI.69.8.4846-4850.2001","article-title":"Immunoglobulin A-mediated protection against Bordetella pertussis infection","volume":"69","author":"Hellwig","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.009_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2006.04.014","article-title":"In search of the elusive mouse macrophage Fc-alpha receptor","volume":"107","author":"Reljic","year":"2006","journal-title":"Immunol Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11010309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:35:21Z","timestamp":1592753721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11010309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":27,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X11010309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}